Skip to main content
PMC home page
Thorax logoLink to Thorax
. 1994 Mar;49(3):218–224. doi: 10.1136/thx.49.3.218

Circulating antibodies to lung protein(s) in patients with cryptogenic fibrosing alveolitis.

W A Wallace 1, S N Roberts 1, H Caldwell 1, E Thornton 1, A P Greening 1, D Lamb 1, S E Howie 1
PMCID: PMC1021149  PMID: 8202877

Abstract

BACKGROUND--It has been hypothesised that cryptogenic fibrosing alveolitis has an immunological pathogenesis mediated by T lymphocytes. It is, however, recognised that patients may show dysregulation of the humoral immune system and that the presence of large numbers of B lymphocytes in open lung biopsies may be associated with a poor prognosis. Evidence of a role for the humoral immune system in the pathogenesis of cryptogenic fibrosing alveolitis has been suggested, but attempts to demonstrate circulating immunoglobulin to antigen within the lung have been inconclusive. METHODS--Plasma samples from 22 patients with cryptogenic fibrosing alveolitis, 22 patients with sarcoidosis, and 17 healthy controls were screened by SDS-PAGE and Western blotting for the presence of autoantibodies to lung proteins derived from cryptogenic fibrosing alveolitis, sarcoid and control lung tissue, as well as four normal non-pulmonary tissues. Possible site(s) of target protein(s) within the lung tissue were identified by immunohistochemical examination using IgG purified from the plasma of six patients and two controls. RESULTS--Eighteen of the plasma samples from patients with cryptogenic fibrosing alveolitis had reactive IgG to lung protein(s) in the 70-90 kDa molecular weight range compared with five of 18 plasma samples from patients with sarcoidosis and one of 17 controls. Plasma from patients with cryptogenic fibrosing alveolitis recognised antigen(s) of the same molecular weight in control and sarcoid lung tissue, but not non-pulmonary tissues, with a similar frequency. Immunohistochemical staining of cryptogenic fibrosing alveolitis biopsy material using IgG purified from plasma samples from patients with cryptogenic fibrosing alveolitis, but not control samples, revealed fine linear positivity in the lung parenchyma in a pattern suggestive of reaction with alveolar lining cells. The pattern was cytoplasmic/membranous and not nuclear. CONCLUSIONS--Patients with cryptogenic fibrosing alveolitis have a high frequency of plasma IgG autoantibodies to protein(s) within lung tissue associated with alveolar lining cells. This is believed to be the site where immunological injury occurs in cryptogenic fibrosing alveolitis, but the significance of these antibodies to the aetiology and pathogenesis is as yet unclear.

Full text

PDF
218

Images in this article

220Image
on p.220
221Image
on p.221
221Image
on p.221
221Image
on p.221
221Image
on p.221
222Image
on p.222

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bronchoalveolar lavage constituents in healthy individuals, idiopathic pulmonary fibrosis, and selected comparison groups. The BAL Cooperative Group Steering Committee. Am Rev Respir Dis. 1990 May;141(5 Pt 2):S169–S202. doi: 10.1164/ajrccm/141.5_Pt_2.S169. [DOI] [PubMed] [Google Scholar]
  2. Campbell D. A., Poulter L. W., Janossy G., du Bois R. M. Immunohistological analysis of lung tissue from patients with cryptogenic fibrosing alveolitis suggesting local expression of immune hypersensitivity. Thorax. 1985 Jun;40(6):405–411. doi: 10.1136/thx.40.6.405. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Corrin B., Dewar A., Rodriguez-Roisin R., Turner-Warwick M. Fine structural changes in cryptogenic fibrosing alveolitis and asbestosis. J Pathol. 1985 Oct;147(2):107–119. doi: 10.1002/path.1711470206. [DOI] [PubMed] [Google Scholar]
  4. Crestani B., Dehoux M., Seta N., Cuer M., Aubier M. Cell surface carbohydrates of rat alveolar type II cells in primary culture. Am J Respir Cell Mol Biol. 1993 Feb;8(2):145–152. doi: 10.1165/ajrcmb/8.2.145. [DOI] [PubMed] [Google Scholar]
  5. Dreisin R. B., Schwarz M. I., Theofilopoulos A. N., Stanford R. E. Circulating immune complexes in the idiopathic interstitial pneumonias. N Engl J Med. 1978 Feb 16;298(7):353–357. doi: 10.1056/NEJM197802162980701. [DOI] [PubMed] [Google Scholar]
  6. Emura M., Nagai S., Takeuchi M., Kitaichi M., Izumi T. In vitro production of B cell growth factor and B cell differentiation factor by peripheral blood mononuclear cells and bronchoalveolar lavage T lymphocytes from patients with idiopathic pulmonary fibrosis. Clin Exp Immunol. 1990 Oct;82(1):133–139. doi: 10.1111/j.1365-2249.1990.tb05416.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Erlinger R., Rauh G., Behr J., Schumacher U., Welsch U., Zöllner N. Similar frequency of autoantibodies against pneumocytes type II and Clara cells in patients with interstitial lung diseases and healthy persons. Klin Wochenschr. 1991 May 3;69(7):297–302. doi: 10.1007/BF01644760. [DOI] [PubMed] [Google Scholar]
  8. Fazel S. B., Howie S. E., Krajewski A. S., Lamb D. B lymphocyte accumulations in human pulmonary sarcoidosis. Thorax. 1992 Nov;47(11):964–967. doi: 10.1136/thx.47.11.964. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Fox B., Shousha S., James K. R., Miller G. C. Immunohistological study of human lungs by immunoperoxidase technique. J Clin Pathol. 1982 Feb;35(2):144–150. doi: 10.1136/jcp.35.2.144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hance A. J., Saltini C., Crystal R. G. Does de novo immunoglobulin synthesis occur on the epithelial surface of the human lower respiratory tract? Am Rev Respir Dis. 1988 Jan;137(1):17–24. doi: 10.1164/ajrccm/137.1.17. [DOI] [PubMed] [Google Scholar]
  11. Haslam P. L. Evaluation of alveolitis by studies of lung biopsies. Lung. 1990;168 (Suppl):984–992. doi: 10.1007/BF02718236. [DOI] [PubMed] [Google Scholar]
  12. Haslam P. L., Thompson B., Mohammed I., Townsend P. J., Hodson M. E., Holborow E. J., Turner-Warwick M. Circulating immune complexes in patients with cryptogenic fibrosing alveolitis. Clin Exp Immunol. 1979 Sep;37(3):381–390. [PMC free article] [PubMed] [Google Scholar]
  13. Kaufmann S. H. Heat shock proteins and the immune response. Immunol Today. 1990 Apr;11(4):129–136. doi: 10.1016/0167-5699(90)90050-j. [DOI] [PubMed] [Google Scholar]
  14. Kradin R. L., Divertie M. B., Colvin R. B., Ramirez J., Ryu J., Carpenter H. A., Bhan A. K. Usual interstitial pneumonitis is a T-cell alveolitis. Clin Immunol Immunopathol. 1986 Aug;40(2):224–235. doi: 10.1016/0090-1229(86)90025-5. [DOI] [PubMed] [Google Scholar]
  15. Meliconi R., Bestagno M., Sturani C., Negri C., Galavotti V., Sala C., Facchini A., Ciarrocchi G., Gasbarrini G., Astaldi Ricotti G. C. Autoantibodies to DNA topoisomerase II in cryptogenic fibrosing alveolitis and connective tissue disease. Clin Exp Immunol. 1989 May;76(2):184–189. [PMC free article] [PubMed] [Google Scholar]
  16. Meliconi R., Lalli E., Borzì R. M., Sturani C., Galavotti V., Gunella G., Miniero R., Facchini A., Gasbarrini G. Idiopathic pulmonary fibrosis: can cell mediated immunity markers predict clinical outcome? Thorax. 1990 Jul;45(7):536–540. doi: 10.1136/thx.45.7.536. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Reynolds H. Y., Fulmer J. D., Kazmierowski J. A., Roberts W. C., Frank M. M., Crystal R. G. Analysis of cellular and protein content of broncho-alveolar lavage fluid from patients with idiopathic pulmonary fibrosis and chronic hypersensitivity pneumonitis. J Clin Invest. 1977 Jan;59(1):165–175. doi: 10.1172/JCI108615. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Rose N. R., Neumann D. A., Herskowitz A. Autoimmune myocarditis: concepts and questions. Immunol Today. 1991 Aug;12(8):253–255. doi: 10.1016/0167-5699(91)90118-D. [DOI] [PubMed] [Google Scholar]
  19. Schwarz M. I., Dreisin R. B., Pratt D. S., Stanford R. E. Immunofluorescent patterns in the idiopathic interstitial pneumonias. J Lab Clin Med. 1978 Jun;91(6):929–938. [PubMed] [Google Scholar]
  20. Spurzem J. R., Saltini C., Crystal R. G. Functional significance of anti-T-lymphocyte antibodies in sarcoidosis. Am Rev Respir Dis. 1988 Mar;137(3):600–605. doi: 10.1164/ajrccm/137.3.600. [DOI] [PubMed] [Google Scholar]
  21. TURNER-WARWICK M., DONIACH D. AUTO-ANTIBODY STUDIES IN INTERSTITIAL PULMONARY FIBROSIS. Br Med J. 1965 Apr 3;1(5439):886–891. doi: 10.1136/bmj.1.5439.886. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Turner-Warwick M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis: response to corticosteroid treatment and its effect on survival. Thorax. 1980 Aug;35(8):593–599. doi: 10.1136/thx.35.8.593. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Wallaert B. Subclinical alveolitis in immunologic systemic disorders. Lung. 1990;168 (Suppl):974–983. doi: 10.1007/BF02718235. [DOI] [PubMed] [Google Scholar]
  24. Wucherpfennig K. W., Weiner H. L., Hafler D. A. T-cell recognition of myelin basic protein. Immunol Today. 1991 Aug;12(8):277–282. doi: 10.1016/0167-5699(91)90126-E. [DOI] [PubMed] [Google Scholar]

Articles from Thorax are provided here courtesy of BMJ Publishing Group

RESOURCES